Patents by Inventor David G. Ho

David G. Ho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SMALL MOLECULES FOR THE TREATMENT OF KINASE-RELATED DISEASES
    Publication number: 20240199597
    Abstract: Disclosed herein are quinazolinyl compounds, compositions, and methods of use thereof. The compounds may be used in the treatment of kinase-related disorders (including cancer, autoimmune disease, and Duchenne muscular dystrophy).
    Type: Application
    Filed: March 22, 2022
    Publication date: June 20, 2024
    Inventors: Dimitrios Iliopoulos, David G. Ho, Iordanis Karagiannidis, Phithi Nguyen, Dimitra Chalkia
  • SMALL MOLECULES FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND CANCER
    Publication number: 20230159498
    Abstract: Disclosed herein are quinazolinyl compounds, compositions, and methods of use thereof. The compounds may be used in the treatment of autoimmune disorders or cancer.
    Type: Application
    Filed: October 6, 2022
    Publication date: May 25, 2023
    Inventors: Dimitrios Iliopoulos, David G. Ho, Iordanis Karagiannidis, Phithi Nguyen, Dimitra Chalkia
  • Small molecules for the treatment of autoimmune diseases and cancer
    Patent number: 11485728
    Abstract: Disclosed herein are quinazolinyl compounds, compositions, and methods of use thereof. The compounds may be used in the treatment of autoimmune disorders or cancer.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: November 1, 2022
    Assignee: Athos Therapeutics, Inc.
    Inventors: Dimitrios Iliopoulos, David G. Ho, Iordanis Karagiannidis, Phithi Nguyen, Dimitra Chalkia
  • SMALL MOLECULES FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND CANCER
    Publication number: 20220073498
    Abstract: Disclosed herein are quinazolinyl compounds, compositions, and methods of use thereof. The compounds may be used in the treatment of autoimmune disorders or cancer.
    Type: Application
    Filed: November 19, 2021
    Publication date: March 10, 2022
    Inventors: Dimitrios Iliopoulos, David G. Ho, Iordanis Karagiannidis, Phithi Nguyen, Dimitra Chalkia
  • Compositions and methods of targeting mutant K-ras
    Patent number: 10344026
    Abstract: Compounds and compositions are presented that inhibit K-Ras, and especially mutant K-Ras. Certain compounds preferentially or even selectively inhibit specific forms of mutant K-Ras, and particularly the G12D mutant form.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: July 9, 2019
    Assignee: NantBio, Inc.
    Inventors: Chunlin Tao, Laxman Nallan, David G. Ho, Qinwei Wang, Paul Weingarten, Anna B. Juncker-Jensen
  • COMPOSITIONS AND METHODS OF TARGETING MUTANT K-RAS
    Publication number: 20180201610
    Abstract: Compounds and compositions are presented that inhibit K-Ras, and especially mutant K-Ras. Certain compounds preferentially or even selectively inhibit specific forms of mutant K-Ras, and particularly the G12D mutant form.
    Type: Application
    Filed: January 18, 2018
    Publication date: July 19, 2018
    Inventors: Chunlin Tao, Laxman Nallan, David G. Ho, Qinwei Wang, Paul Weingarten, Anna B. Juncker-Jensen